Suchergebnisse - "Dietlein, Markus"

PubPharm (264)

1

Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Rosenbrock, J. | Kaul, H. | Oertel, M. | +12

2

Commentary on the latest DGN procedure guidelines for radioiodine therapy for benign thyroid diseases

enthalten in: Nuklearmedizin. Nuclear medicine | 2024

von Dietlein, M. | Drzezga, A. | Schmidt, M.

3

Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma

enthalten in: Leukemia | 2024

von Fuchs, M. | Jacob, A. | Kaul, H. | +26

4

Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma : an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Ferdinandus, J. | van Heek, L. | Roth, K. | +5

5

Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma : Data from the phase III HD17 trial

enthalten in: European journal of haematology | 2023

von van Heek, L. | Weindler, J. | Gorniak, C. | +11

6

From Bench to Bedside : Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [89Zr]Zr-PSMA-DFO

enthalten in: Molecules (Basel, Switzerland) | 2023

von Schomäcker, K. | Dietlein, F. | Muñoz Vázquez, S. | +5

7

PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume

enthalten in: Academic radiology | 2023

von Knaup, H. | Weindler, J. | van Heek, L. | +6

8

Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin’s lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Ferdinandus, J. | van Heek, L. | Roth, K. | +5

9

Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy : a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer

enthalten in: EJNMMI research | 2023

von Heilinger, J. | Weindler, J. | Roth, K. | +5

10

Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer

enthalten in: EJNMMI Research | 2023

von Heilinger, J. | Weindler, J. | Roth, K. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]